Clinical Trials › NCT06223074
Enrolling by InvitationPhase 2
Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Sponsored by Universidad Nacional Autonoma de Mexico
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 80
Target enrollment
Jan 2023
Start date
Jul 2026
Expected completion
Interventions / Treatments
IV Methylprednisolone administrationNasal Methylprednisolone (MT)
Conditions studied
Multiple Sclerosis Relapsing Remitting
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.